Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/25 08:00 | 10/23/25 | NVCT | Health | Drug | Pharmaceutical Preparations | Mosseri Marlio Charles | N1 | T | 9 | P.m | 3,435 | 5.96 | 0 | 576 | 22 | 3,246 | I | |||||||||||||||
12/26/24 08:00 | 12/24/24 | NVCT | Health | Drug | Pharmaceutical Preparations | Bentsur Ron | NJ | DOT | CB,CEO | 2 | P | 119 | 4.87 | 0 | 25 | 1 | 3,271 | D | ||||||||||||||
11/20/24 08:30 | 11/19/24 | NVCT | Health | Drug | Pharmaceutical Preparations | Poradosu Enrique | NJ | O | Chief Sc | 1 | P | 10 | 4.99 | 0 | 2 | 0 | 1,506 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |